This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
Hepatic fibrosis is a condition characterized by the presence of scar tissue in the liver. It is the result of chronic inflammation caused by a variety of factors, including viral infections, alcohol consumption, and certain medications. Fibrosis is associated with a number of diseases, such as cirrhosis, liver cancer, and portal hypertension. The development of hepatic fibrosis is a complex process involving multiple cellular and molecular events. Initially, there is an infiltration of inflammatory cells into the liver. This triggers an inflammatory response, leading to the production of pro-inflammatory cytokines. These cytokines then activate the production of extracellular matrix molecules by hepatic stellate cells. As the extracellular matrix accumulates, it forms fibrous scar tissue, which can eventually lead to cirrhosis. In addition to the inflammatory process, other factors play a role in the development of hepatic fibrosis. Oxidative stress, which is an imbalance between free radicals and antioxidants, has been linked to liver fibrosis. In addition, elevated levels of cytokines and growth factors, as well as genetic factors, may also be involved.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States